This week's issue of ICIS Chemical Business takes a look at the pharmaceuticals and fine chemicals industry. In addition to articles about outsourcing, drug discovery and the competitive outlook, pharmaceutical editor Feliza Mirasol looks at the generic drug market in the wake of the global economic downturn, features editor Clay Boswell covers biologics manufacturers in Asia, and commodities editor Ivan Lerner examines the potential changes in the US pharmaceutical industry that the new administration of President Obama might bring.
